City of Industry, CA -- (SBWIRE) -- 09/06/2018 -- This report studies the global Platelet Rich Plasma (PRP) market status and forecast, categorizes the global Platelet Rich Plasma (PRP) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue.
In 2017, P-PRP is the largest segment of PRP utilized globally and held more than 63% of market share in the global PRP market. Rich content of platelets and growth factors and conventional type of PRP are the key factors that contributed in the dominance of P-PRP segment. Meanwhile, L-PRF is anticipated to be the fastest growing segment during the forecast period from 2017 to 2025.
PRP products are used for improving the rate of injury healing process in sports and orthopedic diseases and as dermal fillers in cosmetic industries. Orthopedic surgery was the largest application segment in 2017, accounting for more than 37% of the global PRP market. Multiple applications of PRP in cosmetic surgeries and its cost-effectiveness are the prominent factors catalyzing growth of this market in cosmetic surgery.
Geographically, in 2017 North America dominated the global PRP market and held more than 53% of the market share. Factors such as increasing number of cosmetic and orthopedic surgeries, key players domiciled in the region and strong awareness about PRP therapy and devices are supporting the dominance of the region. However, Asia-Pacific is estimated to witness strong growth and emerge as the most promising and fastest growing market during the forecast period from 2017 to 2025.
The global Platelet Rich Plasma (PRP) market is valued at 190 million US$ in 2017 and will reach 440 million US$ by the end of 2025, growing at a CAGR of 11.2% during 2018-2025.
The major manufacturers covered in this report
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
The study objectives of this report are:
To analyze and study the global Platelet Rich Plasma (PRP) sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Platelet Rich Plasma (PRP) manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Platelet Rich Plasma (PRP) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/84246ac2308f931e2861bab21862e27f,0,1
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Platelet Rich Plasma (PRP) Manufacturers
Platelet Rich Plasma (PRP) Distributors/Traders/Wholesalers
Platelet Rich Plasma (PRP) Subcomponent Manufacturers
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Platelet Rich Plasma (PRP) market, by end-use.
Detailed analysis and profiles of additional market players.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/135079/global-platelet-rich-plasma-prp-market
QYResearch established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.